Delivery Order SPE2DB20D1047-SPE2DB25FF55J

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,439.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,956,585 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules, in 100-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2025. This award is not a...
This federal contract award, valued at $31,743.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,555,721,400 units of the prescription drug dextroamphetamine-amphetamine 20 mg capsules in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of December 15, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,479.10, is for the delivery of 4,568,033,530 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $1,038.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,176,692 units of Dextroamphetamine-Amphetamine ER 20 mg capsules. The single-award Delivery Order contract, valued at $1,008.00, has a firm fixed price and is set to be completed by October 23, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,310.72 contract is for the supply of 4,567,942,193 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,810.02 and is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award, valued at $3,492.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract, a firm fixed price delivery order with a ceiling value of $4,092.96, is for the supply of 4,564,184,993 units of the pharmaceutical product dextroamphetamine-amphetamine 20 mg capsules. The contract has an ultimate completion date of April 8, 2024. This award is part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,004.80 contract is for the supply of 4,567,927,137 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg Capsules. The contract has an ultimate completion date of April 16, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF55J
    Delivery Order

This federal contract award, valued at $2,103.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,982,989 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules in 100-count bottles.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen, designated as SPE2DX, with a total ceiling value of $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle for the DLA Troop Support Medical, with a performance period through December 2026. The contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract award is not designated as a set-aside, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors. The contract type is Firm Fixed Price, with an ultimate completion date of April 22, 2025.

Generated 7/21/25, 7:43 PM